ArticleYonsei medical journal2016

Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study.

Chang Hwan Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.